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Abstract
Background: Guidelines recommend that clinicians should make brief opportunistic behavioural interventions to
patients who are obese to increase the uptake of effective weight loss programmes. The objective was to assess
the effect of this policy on socioeconomic equity.
Methods: One thousand eight hundred eighty-two consecutively attending patients with obesity and who were
not seeking support for weight loss from their GP were enrolled in a trial. Towards the end of each consultation,
GPs randomly assigned participants to one of two 30-s interventions. In the active intervention (support arm), the
GP offered referral to a weight management group. In the control intervention (advice arm), the GP advised the
patient that their health would benefit from weight loss. Agreement to attend a behavioural weight loss
programme, attendance at the programme and weight loss at 12 months were analysed by socioeconomic
status, measured by postcode using the Index of Multiple Deprivation (IMD).
Results: Mean weight loss was 2.43 kg (sd 6.49) in the support group and 1.04 kg (sd 5.50) for the advice
only group, but these effects were moderated by IMD (p = 0.039 for the interaction). In the support arm,
weight loss was greater in higher socioeconomic groups. Participants from lower socioeconomic backgrounds
were more likely to accept the offer and equally likely to attend a weight loss referral but attended fewer
sessions. Adjusting for these sequentially reduced the gradient for the association of socioeconomic status
with weight loss from + 0.035 to − 0.001 kg/IMD point. In the advice only arm, 10% took effective action to
promote weight loss. The decision to seek support for weight loss outside of the trial did not differ by
socioeconomic status, but weight loss among deprived participants who used external support was greater
than among more affluent participants (p = 0.025).
Conclusion: Participants’ responses to GPs’ brief opportunistic interventions to promote weight loss differed
by socioeconomic status and trial arm. In the support arm, more deprived people lost less weight because
they attended fewer sessions at the programme. In the advice arm, more deprived people who sought and
paid for support for weight loss themselves lost more weight than more affluent people who sought support.
Trial registration: This trial is registered with the ISRCTN registry, number ISRCTN26563137. Date of registration:
January 3, 2013; date of first participant recruited: June 4, 2014
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Introduction
The history of economic development shows that,
broadly speaking, the prevalence of obesity rises with na-
tional wealth very probably because, as populations shift
from rural to urban areas, the variety and amount of
food available increases and manual tasks are replaced
by automation [1, 2]. Obesity emerges first in the most
affluent parts of society, but when a large proportion of
the population become obese, a new trend is evident in
which the most deprived have the highest prevalence of
obesity [3]. This gradient contributes to the observed in-
equities in economic productivity, health outcomes and
life expectancy. This situation calls for a wide-ranging
and comprehensive policy response, designed to bring
proportionally greater benefits to the most deprived
groups. Part of the response will require interventions to
treat established obesity if we are to avoid an unsustain-
able toll of morbidity and mortality in the next 50 years
[4]. However, there are concerns that individually fo-
cused interventions, particularly those that rely on high
levels of individual voluntary effort and organisation,
termed agency, may exacerbate inequalities [5, 6].
Randomised controlled trials (RCTs) have established
that modest weight loss can prevent weight-related mor-
bidity and mortality [7, 8]. Although implementation in
routine practice has proved challenging, RCTs have estab-
lished that widely available commercially provided weight
loss programmes can achieve greater weight loss and
health benefits than self-management approaches, are
cost-effective and can be cost-saving [9, 10]. In the UK,
for example, some local areas can provide free referrals to
community weight loss groups, usually for 12 weeks, as
part of healthcare provision. Despite this, those from more
deprived areas are less likely to use these community
group weight loss programmes [11], even where participa-
tion is offered at no cost as part of a trial [12].
It has been hypothesised that interventions such as
these weight loss programmes which require a high level
of agency to enact may widen social inequalities [5].
Agency refers to motivation, organisation and capacity
including material resources to enact behavioural re-
sponses. Social inequalities in the uptake of weight loss
programmes, even when offered by GPs at no cost to
the participant, all rely on agency to obtain health bene-
fits. Inequalities in the response to intervention may
arise at multiple stages of the pathway, including doctors
offering a referral, patients’ acceptance of the referral, at-
tendance at the programme, continued engagement with
the programme and ability to enact the advice of the
programme and continued attendance at it, all of which
may affect eventual weight loss. Hence, despite being an
effective weight management strategy at a population
level, these weight loss programmes may also serve to
increase inequalities between social groups.
We published an RCT showing that when GPs oppor-
tunistically endorse, offer and facilitate referral of unse-
lected patients who were obese to a commercial weight
management programme, this is well-received and re-
sults in greater weight loss at 1 year than when GPs ad-
vised weight loss alone [13]. In this pre-planned but
exploratory subgroup analysis [14], we examine whether
the outcome differed by deprivation and, if so, where in
the pathway this occurred in both the support arm,
where GPs suggested a referral, and the advice arm,
where they simply advised weight loss would be benefi-
cial. Both arms arguably require agency on the part of
the participant to engage with and enact the advice of-
fered in order to lose weight and improve health.
Methods
Study design and participants
The protocol and the primary outcome have been pub-
lished previously [13, 14]. In brief, this study was a paral-
lel, two-arm, randomised trial of a brief intervention for
obesity conducted in primary care. Researchers screened
consecutively attending patients waiting to see 137 dif-
ferent GPs across the south of England. We sought to
enrol anyone who had a BMI ≥ 25 kg/m2 if they were
Asian or ≥ 30 kg/m2 from all other ethnic groups, and
83% of such people agreed. We excluded people already
attending weight loss programmes or those attending
their GP for the purposes of weight loss support.
Participants had their consultation with the GP as nor-
mal and towards the end were randomised to one of two
opportunistic brief behavioural interventions. In the
‘support’ arm, GPs endorsed, offered and facilitated a re-
ferral to one of two community weight management ser-
vices, which were offered free to participants for 12
weeks. These services were provided commercially by
Slimming World and Rosemary Conley. In the ‘advice’
(control) arm, GPs advised participants to lose weight to
benefit their health. The aim was for GPs to deliver both
interventions within 30 s. The trial had approval from
the NHS Research Ethics Service and is registered
ISRCTN: 26563137.
Independent variable
The independent variable was socioeconomic status,
measured here by the Index of Multiple Deprivation
(IMD) score. IMD score is calculated based on census
data for each lower level super output area (LSOA) that
contains the participant’s postcode. Each area has an
average of 1500 residents. The deprivation score is based
on income, employment, education, health, crime, hous-
ing and living environment of people within that area.
Each area is given a score from 1 to 100. A higher IMD
score indicates higher levels of socioeconomic
deprivation.
Graham et al. BMC Medicine           (2019) 17:51 Page 2 of 9
Outcomes
For this analysis, we used the primary outcome of the
trial, weight change between baseline and 12 months,
and incorporated self-reported weight if the measured
weight was missing. We weighed 1419 (75%) participants
at 12 months and had self-reported weight on an add-
itional 141 (7%). Otherwise, we imputed data using the
baseline observation carried forward (BOCF) method for
people whose weight was completely missing at 12
months (n = 320, 17%).
Researchers recorded whether participants accepted a
referral at the time of the initial consultation, and there-
fore, there were no missing data. We obtained data from
Slimming World on attendance for the majority of those
accepting referrals (94%). Data was collected through
routine systems and used to measure whether partici-
pants attended and the number of sessions attended for
all participants that attended at least once.
We collected data by telephone or in-person interview
on whether participants took action to lose weight at 3
and 12 months. Effective action was defined as taking ac-
tion where there is evidence from trials that using that
approach will lead to greater weight loss than
self-directed weight loss efforts. We classified effective
actions as attending a weight loss programme, prescrip-
tion of orlistat or alli (orlistat bought without prescrip-
tion), or following a total or partial meal replacement
weight loss programme [15, 16].
Statistical analysis
Did weight loss differ by levels of deprivation?
In this and all subsequent analyses, we used generalised
linear mixed effects models with either an identity or lo-
gistic link function depending on whether the outcome
was linear or binary. The randomisation was stratified by
GP, so this term was added as a random effect and the
link function was either a logistic term for binary out-
comes or identity function for continuous outcomes. In
this first analysis, we included baseline weight, trial arm,
IMD score as an untransformed linear term and IMD ×
trial arm. The outcome variable was weight at 12
months. Having found evidence of moderation, we pro-
ceeded to analyse each arm separately to understand the
cause of moderation.
Analyses within the support arm
Within the support arm, we examined whether the pro-
portion of people accepting a referral when offered one
by the GP differed by IMD score. The denominator was
everyone in that arm. Among those who accepted a re-
ferral, we examined whether the proportion that
attended at least one session and the number of sessions
attended were associated with IMD score. Finally, we ex-
amined the association of IMD score with weight loss by
adjusting sequentially for these terms to see whether this
abolished the association between weight loss and IMD
score.
Analyses within the advice arm
In the advice arm, we examined whether there was a dif-
ference by IMD score in participants who subsequently
decided to use an effective form of weight loss support,
mainly attending a commercial weight loss programme
at their own expense. We also examined weight loss by
IMD score, split by whether or not participants took ef-
fective action.
All statistical analyses were conducted according to
the pre-specified statistical analysis plan using SPSS ver-
sion 22. As these were predefined exploratory analyses,
we mainly calculated and present 95% confidence inter-
vals but present p values for analyses to help with the
interpretation.
Results
Descriptive data
Between June 2013 and December 2014, 8403 patients
were screened and 1882 were enrolled in the trial. Nine
hundred forty participants were assigned to the support
intervention and 942 to the advice intervention.
Participants had a mean age of 56.0 years (standard de-
viation (sd) 16.1), 1076 were women (57%) and 96 (5%)
were from minority ethnic groups. The mean baseline
weight was 92.5 kg (sd 15.3) for women and 104.6 kg (sd
15.7) for men, with mean BMI being 34.9 kg/m2 (sd 4.8).
Mean IMD score was 15.7 (sd 11.8) in the advice group
and 16.4 (sd 12.6) in the support group, and it ranged
from 1.3 to 81.8. There was no evidence that people
who declined participation in the trial differed from
those who accepted in terms of age, gender, ethnic group
or BMI, but data on postcode were deemed identifiers
and not available for those who declined to participate.
Figure 1 presents a histogram demonstrating the distribu-
tion of participants’ IMD score in the trial and the frequency
of lower super output areas IMD scores shown by IMD de-
cile (Office for National Statistics, 2015). The distribution of
IMD scores was somewhat similar to that of England as a
whole, but with a higher proportion of more affluent partici-
pants. IMD scores did not differ significantly between indi-
viduals who provided data at 12-month follow-up compared
to those whose data was missing (p= 0.54).
Four hundred one participants in the support group (53%
of those followed up) took effective action by 12months,
while 96 participants did so in the advice group (10%).
Did level of deprivation moderate the effect of trial arm
on weight loss?
At 12 months, weight loss was 2.43 kg (sd 6.49) in the
support group and 1.04 kg (sd 5.50) in the advice group.
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IMD score was a significant moderator of the relation-
ship between group and weight loss (IMD score × group
coefficient was − 0.047, 95%CI − 0.09, − 0.02, p = 0.039).
In the advice group, a higher proportion of deprived par-
ticipants lost more weight at 12 months while in the
support group, this relationship was reversed such that a
higher proportion of deprived participants lost less
weight (Fig. 2).
We therefore proceeded to analyse each arm separ-
ately to determine the possible causes of these differ-
ences. To check the models, we added square terms for
deprivation but they did not improve the fit. We also
plotted the mean weight loss in each decile of the IMD
against the fitted regression line for the support and the
advice arm, showing reasonable fit (see Additional file 1
Figure S1 and S2)
Fig. 1 Frequency distribution of participants’ IMD score in the BWeL trial (top) and distribution of lower super output areas IMD score in England
(bottom)*. *Higher scores represent greater deprivation
Fig. 2 Weight change at 12 months in each trial arm by deprivation
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The support arm
Did the acceptance of an offer differ by level of
deprivation?
In the support group, 722 (77%) participants accepted a
referral to weight management when offered by the GP.
More deprived participants were more likely to accept
the referral, odds ratio (OR) for a 10-point increase in
IMD was 1.20 (95%CI 1.04 to 1.35, p = 0.015; Fig. 3).
Did attendance at a programme differ by level of
deprivation?
Of those participants who accepted a referral to a com-
mercial weight loss programme, 387 participants went
on to attend the class (54%). Attendance following ac-
ceptance of referral was slightly lower among more de-
prived compared to less deprived participants (not
statistically significant). The OR for attendance for a
10-point increase in IMD was 0.92 (95%CI 0.82 to 1.03,
p = 0.17 Fig. 4). However, as more deprived patients were
more likely to accept a referral, there was no evidence
that attending at least one session differed by
deprivation in the whole population, with an odds ratio
of 1.00 (95%CI 0.90 to 1.12, p = 0.99) for a 10-point in-
crease in IMD.
Did the number of subsequent attendances differ by level of
deprivation?
In those participants who attended at least one weight
management session, the mean number of sessions
attended was 8.0 (sd 3.7). People who were more de-
prived attended fewer sessions. For a 10-point increase
in IMD score, the number of attendances declined by −
0.44 (95%CI − 0.8 to − 0.13, p = 0.006, Fig. 5).
Weight loss in those who declined the offer of weight loss
support
Of those participants who were in the support group but
did not accept the referral or attend a weight manage-
ment at 12-month follow-up, there was no evidence that
weight loss differed by levels of deprivation; weight loss
was reduced by 0.18 kg (95%CI − 0.17 to 0.53, p = 0.30)
for every 10-point increase in IMD.
Explaining the association between deprivation and weight
loss in the support arm
The coefficient for the association between deprivation
and weight change in the support arm was 0.035 (95%CI
0.002 to 0.068, p = 0.040). Adjusting for acceptance of
referral slightly strengthened the association to 0.042
(95%CI 0.009 to 0.075, p = 0.012). Adding a term for
whether or not participants attended at least one session
reduced the coefficient slightly to 0.031 (95%CI − 0.008
to 0.069, p = 0.12). However, adjusting for the number of
sessions attended reduced the coefficient to − 0.001
(95%CI − 0.061 to 0.062, p = 0.99).
The advice arm
Taking effective action and effect on weight
In the advice group, 96 (10%) participants took effective
action. There was no evidence this varied by levels of
deprivation. The OR for a 10-point increase in IMD was
0.96 (95%CI 0.79 to 1.17, p = 0.71).
Fig. 3 Proportion of participants accepting a referral to
weight management
Fig. 4 Proportion of participants who attended weight
management having accepted a referral
Fig. 5 Mean number of sessions attended at the weight
management service by participants in the support arm who
attended at least one appointment
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We examined whether the association between weight
loss and deprivation differed by whether or not partici-
pants took effective action by adding a multiplicative
term for effective action × IMD score (Fig. 6). As this
was significant (interaction coefficient = 0.14, 95%CI
0.018 to 0.27, p = 0.025), we examined the association
between IMD and weight loss separately for those who
did and did not take effective action in the advice arm.
Among participants taking effective action, weight loss
was somewhat but not significantly greater with in-
creased deprivation; for every 10-point increase in IMD
score, weight loss was 0.68 kg (95%CI 0.21 to − 0.072, p
= 0.34) greater. Among those not taking effective action,
the coefficient for the association between weight change
and a 10-point increase in IMD was − 0.003 (95%CI −
0.043 to 0.036, p = 0.86) implying almost no association.
Explaining the association between deprivation and weight
loss in the advice arm
The coefficient for the association between weight
change and IMD was − 0.012 (95%CI − 0.042 to 0.019, p
= 0.45). The strength of association was largely un-
changed after adjusting for the use of an effective weight
loss intervention (coefficient = − 0.016, 95%CI − 0.056 to
0.023, p = 0.42).
Discussion
Summary
Socioeconomic deprivation moderated the effect of a brief
opportunistic behavioural intervention on weight change
at 12-month follow-up. In the support group, less de-
prived participants lost more weight, while in the advice
group, more deprived participants lost more weight. In
the support group, socioeconomically deprived partici-
pants were more likely to accept the referral but attended
fewer sessions than those who were less deprived. Adjust-
ing for the number of attendances accounted for the rela-
tionship between deprivation and weight change in the
support group. In the advice group, 10% of people took
effective action to lose weight (predominantly via attend-
ing a commercial weight management programme). The
probability of taking effective action did not differ by level
of deprivation. However, weight loss among those taking
effective action and who lived in deprived localities was
much greater than among those taking action who lived
in more affluent areas. Thus, more deprived participants
were just as likely to take effective action when compared
to less deprived participants but achieved greater weight
loss by doing so.
Strengths and limitations
The unique feature of this study is that the data come
from a trial in which advice to lose weight or the offer of a
referral to a weight management programme was given to
the large majority of patients consulting a physician—a
true test of opportunistic interventions delivered at scale.
We might presume that most patients were not particu-
larly motivated to lose weight, since we excluded patients
who were already actively engaged in a programme or
seeking help to lose weight from their doctor. It therefore
provides the only data of its kind on the impact of oppor-
tunistic weight loss interventions on obesity-related in-
equalities, which current guidelines advocate. A strength
of the study is the rate of follow-up data at 12months
(75% weighed, with an additional 8% reporting their
weight), which is much higher than the typical follow-up
rate of weight loss trials at 12months (63%) [17].
A limitation of the study is that, for practical reasons, we
mostly recruited general practices within 90min’ drive of
Oxford, UK. As such, most areas were more rural and more
affluent than England as a whole. The only large conurbation
that we recruited from was Bristol. There was no evidence of
a difference in enrolment to the trial by age, gender or BMI,
but we could not collect postcode, which we used to assess
differences by deprivation score, on people who declined to
participate. However, only 17% of potential participants de-
clined to take part, meaning that any bias in the uptake by
socioeconomic deprivation is unlikely to have greatly affected
the associations we observed. Although we planned this ex-
ploratory analysis, we did not base the sample size calcula-
tion on the ability to detect associations by socioeconomic
deprivation, in common with most trials. Moreover, we did
not plan a complementary qualitative investigation to specif-
ically understand the socioeconomic differences we ob-
served. Finally, it should be noted that the IMD score used
in the study represents the levels of deprivation based on
participants’ reported postcodes. Thus, IMD indicates the
deprivation of the geographical area in which the participants
live, rather than the individuals themselves.
Comparison with existing literature
A previous systematic review considered a range of in-
terventions to promote healthy eating and reported on
Fig. 6 Weight change at 12 months for participants in the advice
group taking effective action and not taking effective action
by deprivation
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the effects on the outcome by socioeconomic status [18].
Among studies focused on ‘person’ interventions (i.e. in-
dividually based information and education), the results
were mixed; eight studies suggested the intervention ef-
fect was lower in the more deprived, five found no evi-
dence of a difference and five suggested better outcomes
for the more deprived. While the interventions exam-
ined in this review differed from the brief interventions
we studied, we too observed a mixed picture. In our
study, advice to lose weight, but not providing support
to do so, was associated with better outcomes in the
more deprived populations, primarily because some de-
prived people paid for support to lose weight and were
much more successful than more affluent people who
did likewise. However, in the support arm, the GP ac-
tively offered their patients a free weight loss programme
and booked the patient into the programme without the
participant needing to do anything other than agree.
This manifestly requires participants to exercise less
agency than in the advice arm. Nevertheless, in this arm,
people who were more deprived lost less weight than the
more affluent. The results do not support the proposal
that low agency interventions necessarily widen socio-
economic inequalities [5].
Cross-sectional research suggests that people from
more deprived areas are less likely to use community
weight management programmes [11]. Moreover, in a
trial testing a commercial weight loss programme where
people received a letter from their GP encouraging par-
ticipation which comprised free treatment, people who
lived in more deprived areas were less likely to enrol
than their more advantaged peers [12]. In contrast, in
the present analysis where the offer of referral was made
in person by the GP, we found that patients living in
more deprived areas were more likely to accept a refer-
ral. Offering the referral within a consultation led to a
fourfold higher uptake. This suggests that a direct offer
is not only more acceptable overall, but is particularly so
to people in more deprived circumstances. In contrast to
our findings in the support arm and the advice arm, an-
other investigation of people referred by GPs to a com-
mercial weight loss programme showed no evidence of
socioeconomic differences in weight loss outcomes [12].
Taken together, it remains somewhat unclear whether
commercial weight loss programmes have equal reten-
tion, and weight loss by social group and large-scale
evaluations have not reported on this [19, 20].
Implications for research and practice
Although this was a trial-based analysis, the aim was to
assess the impact of current health policy in several
countries, which advocates clinicians give opportunistic
brief interventions to refer people to weight loss pro-
grammes. Given the high rate of recruitment into this
trial and that GPs received only light-touch training, the
trial represents the enactment of current health policy,
which is otherwise largely unadopted [7, 8]. This is im-
portant because obesity is more prevalent in people liv-
ing in more deprived circumstances, and mass provision
of weight loss support is likely to be an important part
of an effective public health response to the problem of
obesity. Even modest weight loss reduces the incidence
of weight-related morbidity and improves cardiovascular
risk factors [21]. Ensuring people in more deprived areas
are able to benefit from these services is a key compo-
nent of a system of proportionate universalism to reduce
inequalities [22]. Community weight management pro-
grammes are an effective intervention with the advan-
tage of an established infrastructure to support mass
delivery [23, 24]. However, if the provision of these ser-
vices is to avoid widening inequalities, careful attention
needs to be paid to the rollout of this support.
This analysis shows clearly that more deprived popula-
tions will gain greater benefit from in-person offers of
support and facilitated access to services, rather than by
a letter and likely also, by inference, informal advertising
of services, which require a proactive response. More-
over, since most of the inequity arises because of poorer
retention in the programmes, attention needs to be paid
to the barriers to attendance and greater efforts by the
programme providers themselves for their more de-
prived users. Previous research has explored potential
barriers to initial attendance and adherence to commu-
nity weight management programmes in populations
from a range of socioeconomic backgrounds [25–27].
Frequently cited barriers have included cost [28, 29],
work commitments [26] and childcare commitments
[27]. However, there is a paucity of research into barriers
that are specific to individuals from deprived areas.
Thus, future research should aim to unpick specific fa-
cilitators and barriers in this population.
Conclusion
When GPs actively offer brief opportunistic interven-
tions to unselected patients who are obese, more de-
prived people seem more likely to accept support but
attend less frequently and lose less weight than more af-
fluent patients. However, when GPs offer advice to lose
weight, subsequent use of support does not differ by
levels of socioeconomic deprivation but weight loss is
greater among the more deprived population.
Additional file
Additional file 1: Evidence of linearity in the support arm and the
advice arm. Figure S1. Weight loss at 12 months in support arm by
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